Zenotech Laboratories Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported total income from operations (net) of INR 3.050 million compared to INR 5.884 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 29.469 million compared to INR 95.123 million a year ago. Loss from ordinary activates before tax was INR 47.431 million compared to INR 111.215 million a year ago. Net loss was INR 47.431 million or INR 1.38 per basic and diluted share before and after extraordinary items compared to INR 111.215 million or INR 3.23 per basic and diluted share before and after extraordinary items a year ago.

For the nine months period, the company reported total income from operations (net) of INR 19.382 million compared to INR 31.855 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 93.697 million compared to INR 154.657 million a year ago. Loss from ordinary activates before tax was INR 147.335 million compared to INR 202.107 million a year ago. Net loss was INR 147.335 million or INR 4.28 per basic and diluted share before and after extraordinary items compared to INR 202.107 million or INR 5.87 per basic and diluted share before and after extraordinary items a year ago.